Work

The Advanced Renal Cell Carcinoma Sorafenib (ARCCS) expanded access trial: Safety and efficacy in patients (pts) with non-clear cell (NCC) renal cell carcinoma (RCC)

Year: 2007

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2007.25.18_suppl.5036

Authors: W. M. Stadler, R. A. Figlin, M. S. Ernstoff, B. Curti, K. Pendergrass, S. Srinivas, V. Canfield, C. Weissman, M. Poulin- Costello, R. M. Bukowski

Institutions: Cleveland Clinic, Providence Portland Medical Center, University of Chicago Medical Center, New York Oncology Hematology, Stanford University

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2342254197

Cites:

Cited by: 40

Related to: 10